Ensinger, Inc. – Trademark Portfolio

Entity Type: 03

Ensinger, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 17 (Rubber Goods) — 11 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include INSULBAR and FORMPLAST. The owner is based in Washington, PA.

365 Meadowlands Boulevard

Washington, PA 15301

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FORMPLAST
FORMPLAST
Registered 1995
ENSIPRO
ENSIPRO
Cancelled 1994
ENSIFONE
ENSIFONE
Cancelled 1993
ENSIFIDE
ENSIFIDE
Cancelled 1993
ENSIKEM
ENSIKEM
Cancelled 1993
ENSICAR
ENSICAR
Cancelled 1993
ENSITEP
ENSITEP
Cancelled 1993
ENSILON
ENSILON
Cancelled 1993
ENSITAL
ENSITAL
Cancelled 1993
ENSIDUR
ENSIDUR
Cancelled 1993
INSULBAR
INSULBAR
Registered 1990

Trademark Classifications

Ensinger, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

17
Rubber Goods (11 filings)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

Frequently Asked Questions

How many trademarks does Ensinger, Inc. have?

Ensinger, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 9 cancelled.

What trademark classes does Ensinger, Inc. file in?

Ensinger, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 17 (Rubber Goods). Class 17 covers unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica.

What are Ensinger, Inc.'s most well-known trademarks?

Ensinger, Inc.'s registered trademark portfolio includes well-known marks such as INSULBAR and FORMPLAST. These are among 2 currently registered trademarks in the portfolio.

What is Ensinger, Inc.'s trademark registration success rate?

Ensinger, Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.